Discontinued — last reported Q2 '23
Products & Services · Gross Profit
Tyvaso — Gross Profit
United Therapeutics Tyvaso — Gross Profit increased by 31.7% to $278.50M in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 43.2%, from $194.50M to $278.50M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ2 2023
Rolls up toGross Profit
How to read this metric
An increase indicates strong pricing power or improved manufacturing efficiency, while a decrease suggests margin compression due to competition or rising production costs.
Detailed definition
This metric measures the total revenue generated from the specific product line minus the direct costs of production. It...
Peer comparison
Comparable to product-level gross profit reported by specialty pharmaceutical companies.
Metric ID:
uthr_segment_tyvaso_gross_profitHistorical Data
9 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $144.10M | $156.40M | $160.30M | $165.80M | $194.50M | $240.70M | $218.50M | $211.50M | $278.50M |
| QoQ Change | — | +8.5% | +2.5% | +3.4% | +17.3% | +23.8% | -9.2% | -3.2% | +31.7% |
| YoY Change | — | — | — | — | +35.0% | +53.9% | +36.3% | +27.6% | +43.2% |
Range$144.10M – $278.50M
CAGR+39.0%
Avg YoY Growth+39.2%
Median YoY Growth+36.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's tyvaso — gross profit?
- United Therapeutics (UTHR) reported tyvaso — gross profit of $278.50M in Q2 2023.
- How has United Therapeutics's tyvaso — gross profit changed year-over-year?
- United Therapeutics's tyvaso — gross profit increased by 43.2% year-over-year, from $194.50M to $278.50M.
- What does tyvaso — gross profit mean?
- The profit remaining from product sales after subtracting the direct costs of manufacturing and distribution.